Samerol-N Tablets for Muscle Pain Relief
Samerol-N tablets are designed to provide effective relief from muscle pain and spasms. The medication contains paracetamol, which helps reduce fever and alleviate additional pain, while orphenadrine citrate works to relieve muscle spasms and discomfort. This combination makes Samerol-N a popular choice for managing acute musculoskeletal conditions, such as joint pain, muscle strain, and injury.
Key Uses:
- Muscle Pain Relief: Orphenadrine helps relieve muscle spasms and pain, while paracetamol provides additional pain relief and reduces fever.
- Skeletal Muscle Relaxation: Often prescribed for acute musculoskeletal conditions to alleviate discomfort associated with muscle strain or injury.
Side Effects:
- Common Side Effects: Drowsiness, dizziness, and lightheadedness. Dry mouth and blurred vision due to the anticholinergic effects of orphenadrine. Gastrointestinal disturbances like nausea and constipation.
- Serious Side Effects: Allergic reactions such as rash, itching, and swelling. Liver damage from excessive paracetamol intake. Severe dizziness or fainting.
Precautions:
- Dosage Caution: Ensure not to exceed the recommended dose of paracetamol, as overdose can lead to severe liver damage.
- Driving and Machinery: Be cautious when performing tasks that require alertness, as orphenadrine may cause drowsiness or impair coordination.
- Alcohol Use: Avoid alcohol while taking this medication, as it can increase the risk of liver damage and enhance sedative effects.
- Medical History: Inform healthcare providers about any history of liver disease, glaucoma, or urinary retention, as orphenadrine can exacerbate these conditions.
Samerol-N tablets are available in packs of 10 tablets and are manufactured by Sami Pharmaceuticals. They are a reliable option for managing various types of pain and muscle discomfort, making them a valuable addition to your medication routine. Always consult your healthcare provider before starting any new medication.
Reviews
There are no reviews yet.